home *** CD-ROM | disk | FTP | other *** search
- MEDICINE, Page 88Grim Legacy of A Banned Pill
-
-
- Phenacetin, a once popular pain killer, can become lethal
-
-
- Even seemingly harmless medications sometimes turn out to
- be delayed-action disasters. Millions of people who once relied
- on the pain killer phenacetin to soothe headaches and aching
- joints have an increased risk of developing kidney disease and
- other life-threatening ailments, according to a report in last
- week's New England Journal of Medicine. The study also raises
- questions about the safety of another popular analgesic,
- acetominophen.
-
- Phenacetin -- the common term for the compound
- acetophenetidin -- is best known as the P in so-called APC
- pills, the now discontinued pick-me-ups that also contained
- aspirin and caffeine. Although phenacetin is still available
- primarily by prescription in some European nations, including
- Germany, Belgium and France, it has been banned in the U.S.
- since 1983 because of its suspected links to anemia and kidney
- disease.
-
- Researchers say anyone who used the drug regularly should
- probably have a thorough medical checkup. The new study, led
- by Dr. Ulrich Dubach of the Basel University Polyclinic in
- Switzerland, compared the health records, over a 20-year
- period, of 623 women, 30 to 49, who took phenacetin daily for
- at least a year with those of 621 women who used the drug less
- often or not at all. The researchers found that women who took
- phenacetin regularly had an increased risk of high blood
- pressure and cardiovascular disease; they were also more likely
- to die from urologic or kidney disease. Aspirin posed no such
- risks.
-
- Chronic users of acetominophen, a close chemical relative
- of phenacetin, may also have cause for concern. Considered
- preferable to aspirin because it rarely produces side effects
- or allergic reactions, does not irritate the stomach and is
- thought to be safe for children and pregnant women,
- acetominophen is sold under such brand names as Tylenol and
- Anacin-3.
-
- "There has already been one study suggesting a link between
- acetominophen and kidney failure," notes Dr. Paul Stolley, of
- the University of Pennsylvania, who wrote a New England Journal
- editorial about the phenacetin study. "The relationship between
- the two drugs makes us want to know more about the possible
- risks." A spokesman for McNeil Consumer Products, manufacturer
- of Tylenol, denies that the new study points to any problems
- with acetominophen.
-
-
-
-
-
-